Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Acute promyelocytic leukemia, FAB M3 |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
Acute myelomonocytic leukemia - eosinophilic variant |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL (disorder) |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
A distinct form of acute myeloid leukemia (AML) in which this chromosomal anomaly is found de novo or in therapy-related AML cases, and is characterized by frequent extramedullary involvement (mainly hepatomegaly, splenomegaly, lymphadenopathies, cutaneous infiltration, but also gum, bone, central nervous system, testicles involvement), severe coagulation disorder (disseminated intravascular coagulopathy or primary fibrinolysis) and poor prognosis. Morphologically, a blast population with a myelomonocytic stage of differentiation is observed. |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
A rare subtype of acute myeloid leukaemia with recurrent genetic abnormalities characterised by clonal proliferation of poorly differentiated myeloid blasts in the bone marrow, blood, or other tissues in patients who present the t(6;9)(p23;q34) translocation. Frequently associated with multilineage bone marrow dysplasia, it usually presents with anaemia, thrombocytopenia (often pancytopenia), and other nonspecific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly). Basophilia, as well as poor response to chemotherapy, has been reported. |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
A subtype of acute myeloid leukemia with recurrent genetic abnormalities characterized by leukocytosis, thrombocytosis and nonspecific symptoms related to ineffective hematopoiesis (fatigue, bleeding and bruising, recurrent infections, bone pain), with frequent extramedullary involvement typically presenting as gingival hyperplasia and lymphadenopathy. The disease is characterized by clonal proliferation of myeloid blasts harboring mutations of the NPM1 gene in the bone marrow, blood and other tissues. It is associated with multilineage dysplasia, involving the myeloid, monocytic, erythroid, and megakaryocytic cell lineages. |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) is a rare subtype of acute myeloid leukemia with recurrent cytogenetic abnormalities characterized by clonal proliferation of myeloid blasts with predominantly megakaryoblastic differentiation in the bone marrow and blood, often with extensive infiltration of the abdominal organs. It occurs typically in infants and usually presents with hepatosplenomegaly, anemia, thrombocytopenia and nonspecific symptoms related to ineffective hematopoiesis (fatigue, bleeding and bruising, recurrent infections). Myelofibrosis and fibrosis of other infiltrated organs is also characteristic of this disease. |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
A subtype of acute myeloid leukaemia with recurrent genetic abnormalities, characterised by clonal proliferation of myeloid blasts harbouring somatic mutations of the CEBPA gene in the bone marrow, blood and, rarely, other tissues. It can present with anaemia, thrombocytopenia, and other nonspecific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly). |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
A subtype of acute myeloid leukemia with recurrent genetic abnormalities characterized by clonal proliferation of myeloid blasts in the bone marrow, blood and, rarely, other tissues. Bone marrow typically shows small, hypolobated megakaryocytes and multilineage dysplasia. Patients typically present with leukocytosis, anemia, variable platelet counts and a variety of nonspecific symptoms related to ineffective hematopoesis (fatigue, bleeding, bruising, recurrent infections, bone pain) and/or extramedullary site involvement (gingivitis, splenomegaly). High resistance to conventional chemotherapy is reported. |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
Acute myeloid leukemia with t(8;21)(q22;q22) RUNX1-RUNX1T1 (disorder) |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
A rare tumor arising from hematopoietic and lymphoid tissues characterized by abnormal proliferation and differentiation of a clonal population of myeloid stem cells carrying unspecific 11q23 abnormalities. Clinical manifestations result from accumulation of malignant myeloid cells within the bone marrow, peripheral blood and other organs, and include leukocytosis, anemia, thrombocytopenia, fatigue, anorexia and weight loss. |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|
A rare acute myeloid leukemia (AML) with recurrent genetic anomaly characterized by the presence of bone marrow and peripheral blood myeloblasts with features ranging from those of minimal differentiation to granulocytic maturation, demonstrating t(9;22)(q34.1;q11.2) or molecular genetic evidence of BCR-ABL1 fusion. Evidence of chronic myeloid leukemia (CML) is absent. Patients most commonly present with leukocytosis with blast predominance and variable anemia and thrombocytopenia. Splenomegaly is less frequent and peripheral blood basophilia lower than in patients with myeloid blast transformation of CML. The disease occurs primarily in adults, and response to traditional AML therapy or tyrosine kinase inhibitor therapy alone is typically poor. |
Is a |
False |
Akute myeloblastische Leukämie mit rekurrenter genetischer Anomalie |
Inferred relationship |
Some |
|